| Literature DB >> 33920177 |
Laura Martínez-Cayuelas1, Pau Sarrió-Sanz2, Antonio Palazón-Bru3, Lidia Verdú-Verdú4, Ana López-López2, Vicente Francisco Gil-Guillén3, Jesús Romero-Maroto2, Luis Gómez-Pérez2.
Abstract
In hysterectomized patients, even though there is still controversy, evidence indicates that in the short term, the vaginal approach shows benefits over the laparoscopic approach, as it is less invasive, faster and less costly. However, the quality of sexual life has not been systematically reviewed in terms of the approach adopted. Through a systematic review, we analyzed (CRD42020158465 in PROSPERO) the impact of hysterectomy on sexual quality and whether there are differences according to the surgical procedure (abdominal or vaginal) for noncancer patients. MEDLINE (through PubMed), Embase, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov and Scopus were reviewed to find randomized clinical trials assessing sexuality in noncancer patients undergoing total hysterectomy, comparing vaginal and abdominal (laparoscopic and/or open) surgery. Three studies that assessed the issue under study were finally included. Two of these had a low risk of bias (Cochrane risk of bias tool); one was unclear. There was significant variability in how sexuality was measured, with no differences between the two approaches considered in the review. In conclusion, no evidence was found to support one procedure (abdominal or vaginal) over another for non-oncological hysterectomized patients regarding benefits in terms of sexuality.Entities:
Keywords: abdominal; hysterectomy; sexuality; vaginal
Year: 2021 PMID: 33920177 PMCID: PMC8069441 DOI: 10.3390/ijerph18083994
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart of the systematic review.
Main characteristics of the articles included in the review.
| References | Population | Age (Years, Mean) | Menopause (%) | Hormone Therapy (%) | Adnexectomy (%) | Design | Intervention | Control | N | N | Outcome | Measurements | Effect |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Garry et al. 2004 [ | Non-malignant hysterectomy | 40.8 (VH) | Unknown | Unknown | Unknown | RCT multicentric | VH | LH | 168 | 336 | QoL (physical and mental) | SF-12 score [ | Neutral |
| Wierrani et al. 1995 [ | Non-malignant hysterectomy | 43.3 | 0 | Unknown | 0 | RCT unicentric | VH | AH, LAVH, CASH | 14 | 27 | Libido and genital sexual sensitivity | Authors’ questionnaire (Likert-type scale) | Neutral |
| Candiani et al. 2009 [ | Non-malignant hysterectomy | 51.2 (VH) | 30 | Unknown | 59 (VH) | RCT unicentric | VH | LH | 30 | 30 | Sexual problems | Dichotomous response | Neutral |
RCT (randomized clinical trial). VH (vaginal hysterectomy). LH (laparoscopic hysterectomy). LAVH (laparoscopic-assisted vaginal hysterectomy). CASH (celioscopy-assisted hysterectomy). QoL (quality of life). SF-12 Score (short-form 12 items score).
Risk of bias according to the Cochrane classification. A final global risk column was added, following “the worst score counts” principle.
| Random Sequence | Allocation | Blinding of Participants | Blinding of Outcome | Incomplete Data Outcome | Selective Reporting | Other Bias | Global | |
|---|---|---|---|---|---|---|---|---|
| Garry et al. [ | Low | Low | Low | Low | Low | Low | Low | Low |
| Wierrani et al. [ | Unclear | Unclear | Low | Low | Low | Unclear | Low | Unclear |
| Candiani et al. [ | Low | Low | Low | Low | Low | Low | Low | Low |